MelenhorstLab Profile
MelenhorstLab

@MelenhorstLab

Followers
221
Following
398
Media
2
Statuses
140

Multinational team focused on curing cancer with cell therapy & immuno-engineering. Product safety, efficacy, reproducibility, and affordability are key.

Cleveland, OH
Joined January 2022
Don't wanna be here? Send us removal request.
@MelenhorstLab
MelenhorstLab
10 months
RT @GuedanS: 👏 Congrats to Prof. @carlhjune on receiving the @AbarcaPrize! His pioneering work in CAR-T therapy has transformed cancer trea….
0
2
0
@MelenhorstLab
MelenhorstLab
10 months
RT @WickstromLab: Excited to share our latest work on an image analysis paradigm that combines cell state and morphology analyses of patien….
0
82
0
@grok
Grok
2 days
Join millions who have switched to Grok.
114
208
2K
@MelenhorstLab
MelenhorstLab
11 months
RT @TylerAlban1: Super cool to see our work highlighted by @ACIR_org If you haven’t had a chance to check it out yet this is a great summar….
0
4
0
@MelenhorstLab
MelenhorstLab
2 years
RT @dana_peer: Super excited to share the final publication of Spectra, fruit of the wonderful collaboration between .@russell_kunes and @….
0
62
0
@MelenhorstLab
MelenhorstLab
2 years
Had my favorite book in my checked in luggage - which apparently left out in the rain. Now I am thinking again: buy the book or read this tortured copy? Thoughts?
Tweet media one
0
0
2
@MelenhorstLab
MelenhorstLab
3 years
North Korea tensions: Why is Kim Jong-un upping the pressure? Not so super, man!
bbc.co.uk
As the Koreas trade warning shots, the situation on the peninsula is at its most volatile in years.
0
0
0
@MelenhorstLab
MelenhorstLab
3 years
Nedd Brockmann: The man who ran across Australia in 47 days….Superman.
0
0
1
@MelenhorstLab
MelenhorstLab
3 years
RT @jamecancerdoc: We are looking for doctors who are interested in Hematology and Oncology Hospitalist positions @ClevelandClinic https://….
0
16
0
@MelenhorstLab
MelenhorstLab
3 years
Tom, his wife Kari and Emily are among the most courageous people I know. What a journey it’s been for them. Thankful for their mission to guide other families.
0
0
3
@MelenhorstLab
MelenhorstLab
3 years
At today’s Chagrin Falls Documentary Film festival where I was invited for the Q&A following Ross Kauffman’s Of Medicine and Miracles movie showing. Made new friends, reconnected with Tom Whitehead. Saw Carl in this movie as I know him: Brilliant, inspiring, miles ahead of every1
Tweet media one
Tweet media two
1
3
15
@MelenhorstLab
MelenhorstLab
3 years
RT @GeneCollector: Here is an alternative to BioRender that is TRULY FREE and actively maintained. Over 1500 vector….
0
814
0
@MelenhorstLab
MelenhorstLab
3 years
I wouldn’t say “starting” but “advancing our understanding. ”. Great progress with high translational potential!
Tweet card summary image
statnews.com
“As you engineer your CAR-T cells, you can make sure they’re not fighting against each other,” a cancer researcher suggests in light of new findings.
0
2
7
@MelenhorstLab
MelenhorstLab
3 years
RT @WangXiaoLab: Excited to share TEMPOmap, our new spatiotemporal transcriptomics method that integrates metabolic labeling with 3D in sit….
Tweet card summary image
biorxiv.org
Spatiotemporal regulation of the cellular transcriptome is crucial for proper protein expression and cellular function[1][1]. However, the intricate subcellular dynamics of RNA synthesis, decay,...
0
67
0
@MelenhorstLab
MelenhorstLab
3 years
RT @CleClinicNews: Cleveland Clinic is selected as the leading healthcare system in a new initiative to accelerate collaboration and innova….
0
17
0
@MelenhorstLab
MelenhorstLab
3 years
RT @GeneCollector: Applications open for a pediatric oncology physician scientist. Pediatric neuro-oncology focused clinical practice and l….
0
8
0
@MelenhorstLab
MelenhorstLab
3 years
RT @Chrystal_Paulos: CAR-T Day in Lille France has been a wonderful meeting. Highly recommended! ⁦@MelenhorstLab⁩ ⁦@PaulosLab⁩ ⁦@KlebanoffL….
0
5
0
@MelenhorstLab
MelenhorstLab
3 years
Interesting work from Scholler, Galon and colleagues on the baseline and post-CAR T cell treatment tumor microenvironment analysis. Plenty of material for mechanistic studies. Congrats to the team!
Tweet card summary image
nature.com
Nature Medicine - Analysis of tumor biopsies from the pivotal phase 1/2 ZUMA-1 trial identifies pre-treatment T cell–related characteristics that are associated with clinical response and...
1
13
60
@MelenhorstLab
MelenhorstLab
3 years
RT @RongFan8: Honored and humbled to be inducted to NAI. Believe in technology innovation for science, humanity, inclusion and patients! @A….
0
6
0
@MelenhorstLab
MelenhorstLab
3 years
RT @humanimmunenews: Collaborators at @UPennIBI and @YaleBME unveiled molecular mechanisms ⚙️ that may inform strategies to boost specific….
0
2
0
@MelenhorstLab
MelenhorstLab
3 years
RT @KlebanoffLab: Impressive phase 1 trial results testing a Claudin18.2-specific CAR in patients with R/R #GImalignancies. Favorable toxic….
0
7
0